IO Biotech Inc

NASDAQ IOBT

Data sourced from iex and EODHD
Download Data

IO Biotech Inc Income Statement 2020 - 2024

This table shows the Income Statement for IO Biotech Inc going from 2020 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-03-31
Revenue
M 1 1 0 0 0 0 0 0 0 0 0 0 0 0 - -
Cost of Revenue
M 1 1 1 - - - - - - - - - - - - -
Gross Profit
M 0 0 -1 - - - - - - - - - - - - -
Operating Expenses
M 94 92 83 - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 23 24 23 23 24 24 23 21 17 11 6 4 2 1 1 -
Research and Development (R&D) Expenses
M 70 68 60 53 49 47 49 43 38 30 16 15 8 5 3 -
Other Operating Expenses
M 0 0 -1 - - - - - - - - - - - - -
Costs and Expenses
M 93 90 83 - - - - - - - - - - - - -
Operating Income
M -94 -91 -84 -76 -72 -71 -72 -64 -54 -41 -22 -19 -10 -6 -3 -
Interest Expense
M 1 0 1 -1 -1 0 0 0 0 0 0 0 0 0 0 -
Non-operating Income/Expense
M 3 3 2 3 3 1 0 3 -26 -26 -27 -29 0 0 0 -
EBT
M -88 -85 -78 -72 -70 -70 -72 -61 -81 -68 -49 -48 -10 -6 -3 -
Income Tax Provision
M 1 1 1 2 2 1 0 0 0 0 0 0 0 0 0 -
Income after Tax
M -88 -86 -80 -74 -71 -71 -73 -62 -81 -64 -46 -44 -6 -6 -3 -
Non-Controlling Interest
M 0 0 0 0 0 0 1 3 -17 -15 -16 -19 2 - - -
Net Income
M -43 -60 -80 -74 -71 -71 -74 -65 -67 -56 -33 -31 -13 -8 -8 -4
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 52,686,349.50 43,419,937.75 34,153,526.00 28,815,267.00 28,815,267.00 28,815,267.00 28,043,261.25 27,271,255.50 22,954,488.25 18,637,721.00 15,092,959.50 11,548,198.00 11,548,198.00 11,548,198.00 11,548,198.00 -
EBITDA
M -90 -87 -79 -72 -70 -70 -71 -60 -81 -68 -49 -48 -10 -6 -3 -
Depreciation and Amortization
M 2 3 4 3 3 2 -48 -46 -75 -76 -27 -30 0 0 0 -
EBIT
M -93 -90 -82 -75 -72 -71 -23 -15 -5 8 -22 -19 -12 -8 -6 -2
Income from Discontinued Operations
M - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -1.03 -1.10 -2.05 -2.73 -2.23 -1.72 -0.50 -0.69 -0.60 -0.67 -0.71 -0.27 -0.32 -0.32 -0.20 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Gross Profit Margin
% 81.89 81.89 - - - - - - - - - - - - - -
Operating Income Margin
% -2,539.01 -2,539.01 - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - -
EBITDA Ratio
% -2,520.90 -2,520.90 - - - - - - - - - - - - - -
EBIT Ratio
% -2,539.01 -2,539.01 - - - - - - - - - - - - - -
EBT Ratio
% -2,326.94 -2,326.94 - - - - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email